Joaquim Vila

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

Olga Salamero, Pau Montesinos, Christophe Willekens et al. · Journal of Clinical Oncology · 2020 · 112 citations · Full text

Medicine, Oncology, Pharmacology +16

Trough-to-Peak Ratio, Smoothness Index, and Circadian Blood Pressure Profile After Treatment With Once-Daily Fixed Combination of Losartan 100 and Hydrochlorothiazide 25 in Essential Hypertension

António Coca, Javier Sobrino, J. Soler et al. · Journal of Cardiovascular Pharmacology · 2002 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17

XPD, XPA, ERCC1 and XPG/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin-treated colorectal cancer (CRC)

Joaquim Vila, I. Moreno, Mariano Monzó et al. · Journal of Clinical Oncology · 2004 · 17 citations

Medicine, Molecular Genetics, Oncology +14